| 摘要 |
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): wherein W, V, x, y, R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, R<7>, R<7>a, R<8>, R<8>a, R<9>, R<9a>, R<10> and R<10a> are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed. |
| 申请人 |
XENON PHARMACEUTICALS INC.;ABREO, MELWYN;HARVEY, DANIEL, F.;KONDRATENKO, MIKHAIL, A.,;LI, WENBAO;KAMBOJ, RAJENDER;KODUMURU, VISHNUMURTHY;WINTHER, MICHAEL, D.;GSCHWEND, HEINZ, W.;CHAKKA, NAGASREE;LIU, SHIFENG;SVIRIDOV, SERGUEI;SUN, SHAOYI |
发明人 |
ABREO, MELWYN;HARVEY, DANIEL, F.;KONDRATENKO, MIKHAIL, A.,;LI, WENBAO;KAMBOJ, RAJENDER;KODUMURU, VISHNUMURTHY;WINTHER, MICHAEL, D.;GSCHWEND, HEINZ, W.;CHAKKA, NAGASREE;LIU, SHIFENG;SVIRIDOV, SERGUEI;SUN, SHAOYI |
